Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cosmos Health Inc. - Common Stock (NQ:COSM)

0.3939 -0.0261 (-6.21%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Cosmos Health Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Cosmos Health Inc. Announces Successful Closing of $32.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market
Via ACCESSWIRE
Cosmos Health Inc. Announces Pricing of $32.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market
Via ACCESSWIRE
Cosmos Holdings Inc. Changes its Name to Cosmos Health Inc. and Announces a 1-For-25 Reverse Stock Split
Via ACCESSWIRE
Cosmos Health Retains Shareholder Intelligence Services, LLC
Via ACCESSWIRE
Cosmos Health Requests Appeal from the Nasdaq Stock Market
Via ACCESSWIRE
Cosmos Health Enters into a Warrant Exchange Agreement, Replacing Structured Warrants with Plain-Vanilla Warrants
Via ACCESSWIRE
MarketBeat: Week in Review 11/28 – 12/02
Investors continue to monitor the Federal Reserve, but the MarketBeat team helps you look past the headlines. Here are the stories moving the market this week 
Via MarketBeat
Topics Cannabis Economy Stocks
Cosmos Health Provides a Summary Regarding Recent Share Activity and Reiterates its Belief and Commitment to the Financial Strength and the Growth and Profitability of the Company
Via ACCESSWIRE
Cosmos Holdings May be a Long-Term Buy with Short-Term Risk
Cosmos Holdings stock is up 618% in November likely due to a short squeeze. This article explains why Cosmos Holdings may still be a good long-term investment 
Via MarketBeat
Topics Intellectual Property
Cosmos Health Enters the Development Phase for CCX0722, an Innovative Product for Obesity and Weight Management
Via ACCESSWIRE
Cosmos Health to Sell its Sky Premium Life Luxury Food Supplement Brand on Iberian Airlines' In-flight Magazine, Ronda.
Via ACCESSWIRE
Cosmos Health Reports Third Quarter 2022 Financial Results
Via ACCESSWIRE
Cosmos Health Obtains Exclusive Rights to Market and Distribute Nickelodeon's SpongeBob and PAW Patrol Kids' Vitamins in Greece and Cyprus
Via ACCESSWIRE
Cosmos Health Announces Pricing of $7.5 Million Upsized Public Offering
Via ACCESSWIRE
Cosmos Health Enters into Letter of Intent for the Acquisition of ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.
Via ACCESSWIRE
Cosmos Health Signs an Agreement with Virax Biolabs to Distribute Monkeypox Virus Real-Time PCR Detections Kits in Europe
Via ACCESSWIRE
Cosmos Health Signs Another Distribution Deal; Expedites Sales Reach Into German And Austrian Markets ($COSM)
Via AB Newswire
Cosmos Health to Launch Sky Premium Life Nutritional Supplement Products in Germany and Austria via Amazon and Ebay
Via ACCESSWIRE
Cosmos Health Shares Surge 27%, Decoupling From A Decidedly Bearish Market ($COSM)
Via AB Newswire
Cosmos Health Posted A 202% Increase In Adjusted EBITDA In 1H/2022; Here’s Why 2H/2022 Is Expected To Be Even Better ($COSM)
Via AB Newswire
Cosmos Health Launches First Sky Premium Life Nutritional Supplement Products on Amazon in the United States
Via ACCESSWIRE
Cosmos Health Reports 202.42 % Increase in Adjusted EBITDA and Positive Operating Income for the First Half of 2022
Via ACCESSWIRE
Cosmos Holdings Announces Name Change to Cosmos Health, Reflecting Company's Evolution into an Innovative Global Healthcare Group, Driven by One Purpose: Improving People's Lives
Via ACCESSWIRE
Cosmos Holdings Appoints Dr. Manfred Ziegler to its Advisory Board
Via ACCESSWIRE
Cosmos Holdings Appoints Dr. Manfred Ziegler to its Advisory Board
CHICAGO, IL / ACCESSWIRE / July 22 , 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of... 
From Cosmos Holdings, Inc.
Via AccessWire
Cosmos Holdings Announces Agreement to Acquire Cana Laboratories, a Legacy European Pharmaceutical Company Established in 1928; Vertically Integrating its Manufacturing and R&D Capabilities and Expanding its Product Pipeline with New Brands
Via ACCESSWIRE
Cosmos Holdings Announces Agreement to Acquire Cana Laboratories, a Legacy European Pharmaceutical Company Established in 1928; Vertically Integrating its Manufacturing and R&D Capabilities and Expanding its Product Pipeline with New Brands
CHICAGO, IL / ACCESSWIRE / July 20, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of... 
From Cosmos Holdings, Inc.
Via AccessWire
Cosmos Holdings Subsidiary Granted Full Membership in PAGB, A UK-based Consumer Healthcare Association
Products will be listed on PAGB's OTC Directory online, a go-to resource for healthcare professionals 
From Cosmos Holdings, Inc.
Via AccessWire
Cosmos Holdings Appoints Dr. Panagiotis Zoumpoulakis to its Advisory Board
CHICAGO, IL / ACCESSWIRE / July 8, 2022 / Cosmos Holdings, Inc. ("the Company") (Nasdaq:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of... 
From Cosmos Holdings, Inc.
Via AccessWire
Cosmos Holdings to Acquire LIFE NLB Portfolio of Bone Health Products that Target the Gastrointestinal Microbiome
Acquisition will include all launched and under development bone health products 
From Cosmos Holdings, Inc.
Via AccessWire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.